(Q68102325)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3265653%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

title

Interleukin-3 and interleukin-4 each strongly inhibit the induction and function of human LAK cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3265653%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

author name string

Gallagher G

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3265653%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Wilcox F

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3265653%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

al-Azzawi F

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3265653%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

publication date

1 November 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3265653%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

21 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3265653%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3265653%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3265653%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

page(s)

166-170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3265653%20AND%20SRC:MED&resulttype=core&format=json

Immunotherapy of cancer using interleukin 2: current status and future prospects

21 September 2019

cites work

1 reference

12 December 2020

Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities

1 reference

12 December 2020

Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes

1 reference

12 December 2020

Immunological regulation of hematopoietic/lymphoid stem cell differentiation by interleukin 3.

1 reference

12 December 2020

Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells

1 reference

12 December 2020

Assays detecting the antibody-dependent and independent binding and cytolysis of tumor cells by murine macrophages

1 reference

12 December 2020

Physiology of natural killer cells. In vivo regulation of progenitors by interleukin 3

1 reference

12 December 2020

Human antibodies to ovarian cancer antigens secreted by lymphoblastoid cell lines.

1 reference

12 December 2020

Adoptive immunotherapy of cancer with activated lymphocytes and interleukin-2.

1 reference

12 December 2020

Recombinant interleukin 4 promotes the growth of human T cells

1 reference

12 December 2020

Interleukin 4 (B cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells

1 reference

12 December 2020

Separate but complementary roles for the two forms of interleukin 1 in the growth of transformed human B lymphoblasts

1 reference

12 December 2020

Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.

1 reference

12 December 2020

Identifiers

1 reference